Robin Buchanan

Quick Facts

Intro

American businessman

Places

United States of America

Businessperson

Work field

Business

Gender

Male

The details (from wikipedia)

Biography

Robin Buchanan is Chairman of Michael Page International plc, the FTSE global specialist recruitment company. He is a non-executive director of Schroders plc, the FTSE 100 global asset management company and LyondellBasell NV, the NYSE Fortune 500 $50billion petro-chemicals and refinery company. He chairs the Investment Committee of Access Industries, a family holding company. Robin is also a Senior Adviser to Bain & Company and to Coller Capital. In addition, he is a trustee of Trees for Life, the conservation charity dedicated to restoring the Caledonian Forest.
Robin is the former Dean and President of London Business School. Under his leadership the School was ranked number one in the world for both its MBA and Executive MBA programmes.
Before joining London Business School in 2007, he spent 25 years at Bain & Company. He joined Bain in 1982, becoming partner in 1986. He was elected the Managing Partner of Bain in the UK in 1990 and appointed the Senior Partner for the UK and South Africa in 1996. He was a member of the management buy-out team that acquired Bain in 1991. From 1990 to 2007 the UK business grew at over 25% per annum. He also served as a member of the Management Committee, Compensation Committee and chaired the Nominating Committee of the worldwide Board of Directors. He headed both the worldwide Acquisitions & Alliances practice and the UK Organisational Enhancement and Change Management practice.
From 1979 to 1982 Robin worked for American Express International Banking Corporation, now part of Standard Chartered. Prior to that he was employed by Mann Judd Landau (now Deloitte & Touche) and McKinsey & Company.
He was a director of Liberty International plc, the FTSE100 property company, where he chaired the Remuneration Committee and sat on the Audit, Nominations and Chairman’s Committees. He was also a director of Shire plc, the FTSE100 pharmaceuticals company, and sat on its Remuneration Committee.
Robin is an adviser to private equity firms, family offices and voluntary organisations.
He is a published author on strategy, acquisitions, customer loyalty, leadership, board effectiveness and corporate governance, remuneration, family companies and private equity (see articles).
Robin was awarded an MBA with High Distinction from Harvard Business School, where he was a Baker Scholar and member of the Harvard Business School Rugby Club. He is a Fellow of the Institute of Chartered Accountants of England & Wales. and Financial Services Authority "Approved Person".